{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/10972"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/10972","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Colon-26 cancer-induced skeletal muscle wasting is IKKbeta/IkappaBalpha-dependent and NF-kappaB-Independent","abstract":"Existing data suggest that NF-kappaB signaling is a key regulator of cancer-induced skeletal muscle wasting. However, identification of the components of this signaling pathway and of the NF-kappaB transcription factors that regulate wasting is far from complete. In muscles of C26 tumor-bearing mice, overexpression of dominant-negative (d.n.) IKKbeta and the IkappaBalpha-super repressor blocked wasting by 69% and 41%, respectively. In contrast, overexpression of d.n. IKKalpha or d.n. NIK did not block C26-induced muscle wasting. Surprisingly, overexpression of d.n. RelA (p65) or d.n. c-Rel did not significantly affect muscle wasting. Genome-wide mRNA expression arrays showed upregulation of many genes previously implicated in muscle atrophy. To test if these upregulated genes were direct targets of NF-kappaB transcription factors, we compared genome-wide p65 binding to DNA in control and cachectic muscle using chromatin immunoprecipitation-sequencing (ChiP-seq). Bioinformatic analysis of ChiP-sequencing data from control and C26 muscles did not show p65 binding peaks in the upregulated genes as reflected by the expression arrays. The p65 ChiP-seq data are consistent with our finding of no significant change in protein binding to an NF-kappaB oligonucleotide in an electrophoretic mobility shift assay (EMSA), no activation of an NF-kappaB-dependent reporter, and no effect of d.n. p65 overexpression in muscles of tumor-bearing mice. Taken together, these data support the idea that although inhibition of IkappaBalpha, and particularly IKKbeta, blocks cancer-induced muscle wasting, the alternative NF-kappaB signaling pathway is not required. In addition, the downstream NF-kappaB transcription factors are not involved in gene regulation during atrophy. These data are consistent with the growing body of literature showing that there are NF-kappaB-independent activities of IKKbeta and IkappaBalpha that regulate physiological processes.","abstract_html":"Existing data suggest that NF-kappaB signaling is a key regulator of cancer-induced skeletal muscle wasting. However, identification of the components of this signaling pathway and of the NF-kappaB transcription factors that regulate wasting is far from complete. In muscles of C26 tumor-bearing mice, overexpression of dominant-negative (d.n.) IKKbeta and the IkappaBalpha-super repressor blocked wasting by 69% and 41%, respectively. In contrast, overexpression of d.n. IKKalpha or d.n. NIK did not block C26-induced muscle wasting. Surprisingly, overexpression of d.n. RelA (p65) or d.n. c-Rel did not significantly affect muscle wasting. Genome-wide mRNA expression arrays showed upregulation of many genes previously implicated in muscle atrophy. To test if these upregulated genes were direct targets of NF-kappaB transcription factors, we compared genome-wide p65 binding to DNA in control and cachectic muscle using chromatin immunoprecipitation-sequencing (ChiP-seq). Bioinformatic analysis of ChiP-sequencing data from control and C26 muscles did not show p65 binding peaks in the upregulated genes as reflected by the expression arrays. The p65 ChiP-seq data are consistent with our finding of no significant change in protein binding to an NF-kappaB oligonucleotide in an electrophoretic mobility shift assay (EMSA), no activation of an NF-kappaB-dependent reporter, and no effect of d.n. p65 overexpression in muscles of tumor-bearing mice. Taken together, these data support the idea that although inhibition of IkappaBalpha, and particularly IKKbeta, blocks cancer-induced muscle wasting, the alternative NF-kappaB signaling pathway is not required. In addition, the downstream NF-kappaB transcription factors are not involved in gene regulation during atrophy. These data are consistent with the growing body of literature showing that there are NF-kappaB-independent activities of IKKbeta and IkappaBalpha that regulate physiological processes.","abstract_has_math":false,"creators":["Cornwell, Evangeline Wang"],"institution":"Boston University","degree_name":"Doctor of Philosophy","degree_level":"doctoral","degree_discipline":"Health Sciences","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014","date_published":"2014","updated_at":"2026-11-18T19:26:33Z","subjects":[],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/10972","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/10972","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F10972","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Cornwell, Evangeline Wang"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2015-04-24T19:50:28Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2015-04-24T19:50:28Z"]},{"key":"dc:date.issued","label":"Date","values":["2014"]},{"key":"dc:date.submitted","label":"Dc Date Submitted","values":["2014"]},{"key":"dc:publisher","label":"Institution","values":["Boston University"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Health Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/10972"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Boston University"]},{"key":"dc:description.abstract","label":"Abstract","values":["Existing data suggest that NF-kappaB signaling is a key regulator of cancer-induced skeletal muscle wasting. However, identification of the components of this signaling pathway and of the NF-kappaB transcription factors that regulate wasting is far from complete. In muscles of C26 tumor-bearing mice, overexpression of dominant-negative (d.n.) IKKbeta and the IkappaBalpha-super repressor blocked wasting by 69% and 41%, respectively. In contrast, overexpression of d.n. IKKalpha or d.n. NIK did not block C26-induced muscle wasting. Surprisingly, overexpression of d.n. RelA (p65) or d.n. c-Rel did not significantly affect muscle wasting. Genome-wide mRNA expression arrays showed upregulation of many genes previously implicated in muscle atrophy. To test if these upregulated genes were direct targets of NF-kappaB transcription factors, we compared genome-wide p65 binding to DNA in control and cachectic muscle using chromatin immunoprecipitation-sequencing (ChiP-seq). Bioinformatic analysis of ChiP-sequencing data from control and C26 muscles did not show p65 binding peaks in the upregulated genes as reflected by the expression arrays. The p65 ChiP-seq data are consistent with our finding of no significant change in protein binding to an NF-kappaB oligonucleotide in an electrophoretic mobility shift assay (EMSA), no activation of an NF-kappaB-dependent reporter, and no effect of d.n. p65 overexpression in muscles of tumor-bearing mice. Taken together, these data support the idea that although inhibition of IkappaBalpha, and particularly IKKbeta, blocks cancer-induced muscle wasting, the alternative NF-kappaB signaling pathway is not required. In addition, the downstream NF-kappaB transcription factors are not involved in gene regulation during atrophy. These data are consistent with the growing body of literature showing that there are NF-kappaB-independent activities of IKKbeta and IkappaBalpha that regulate physiological processes."]},{"key":"dc:title","label":"Title","values":["Colon-26 cancer-induced skeletal muscle wasting is IKKbeta/IkappaBalpha-dependent and NF-kappaB-Independent"]}]}],"canonical_facts":{"dc:creator":["Cornwell, Evangeline Wang"],"dc:date.accessioned":["2015-04-24T19:50:28Z"],"dc:date.available":["2015-04-24T19:50:28Z"],"dc:date.issued":["2014"],"dc:date.submitted":["2014"],"dc:description":["Thesis (Ph.D.)--Boston University"],"dc:description.abstract":["Existing data suggest that NF-kappaB signaling is a key regulator of cancer-induced skeletal muscle wasting. However, identification of the components of this signaling pathway and of the NF-kappaB transcription factors that regulate wasting is far from complete. In muscles of C26 tumor-bearing mice, overexpression of dominant-negative (d.n.) IKKbeta and the IkappaBalpha-super repressor blocked wasting by 69% and 41%, respectively. In contrast, overexpression of d.n. IKKalpha or d.n. NIK did not block C26-induced muscle wasting. Surprisingly, overexpression of d.n. RelA (p65) or d.n. c-Rel did not significantly affect muscle wasting. Genome-wide mRNA expression arrays showed upregulation of many genes previously implicated in muscle atrophy. To test if these upregulated genes were direct targets of NF-kappaB transcription factors, we compared genome-wide p65 binding to DNA in control and cachectic muscle using chromatin immunoprecipitation-sequencing (ChiP-seq). Bioinformatic analysis of ChiP-sequencing data from control and C26 muscles did not show p65 binding peaks in the upregulated genes as reflected by the expression arrays. The p65 ChiP-seq data are consistent with our finding of no significant change in protein binding to an NF-kappaB oligonucleotide in an electrophoretic mobility shift assay (EMSA), no activation of an NF-kappaB-dependent reporter, and no effect of d.n. p65 overexpression in muscles of tumor-bearing mice. Taken together, these data support the idea that although inhibition of IkappaBalpha, and particularly IKKbeta, blocks cancer-induced muscle wasting, the alternative NF-kappaB signaling pathway is not required. In addition, the downstream NF-kappaB transcription factors are not involved in gene regulation during atrophy. These data are consistent with the growing body of literature showing that there are NF-kappaB-independent activities of IKKbeta and IkappaBalpha that regulate physiological processes."],"dc:identifier.uri":["https://hdl.handle.net/2144/10972"],"dc:language.iso":["en_US"],"dc:publisher":["Boston University"],"dc:title":["Colon-26 cancer-induced skeletal muscle wasting is IKKbeta/IkappaBalpha-dependent and NF-kappaB-Independent"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Health Sciences"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T19:26:33Z"}